Malaghan ties the knot with China for cancer vaccine trials
Kiwis are being guaranteed the first bite at new cancer vaccines set to be developed and trialled on our shores through Wellington’s Malaghan Institute of Medical Research.
The venture, aimed at developing vaccine based immunotherapy treatments, was formalised today in an agreement with Chinese researchers.
Wellington Zhaotai Therapies has been formed for the venture, with a focus on transfusion-style CAR-T cell therapy, Malaghan Institute director Professor Graham Le Gros said.
